no scripts enabled
Search for medical products or brands
Biogenix NS1 Dengue Rapid Card -  50 Test (BIR-003)

View Product Details


Enhanced imagery for representation purposes. Actual product may vary.

Biogenix NS1 Dengue Rapid Card - 50 Test (BIR-003)


Exclusive of 12% GST

KYC is needed to buy this product.

See why?
Pack Size

50 Test

Variant unavailable, Please select another variant

Check delivery date at your location

View EMI T&C here

Purchase with Credit

Get Interest-free credit with easy and quick approval & hassle free payments

credit icon

MB Benefits

Know More


7 Day Replacement


Hassle Free

Product Details

Description: The Biogenix NS1 Dengue Rapid Card (BIR-003) is a rapid and effective diagnostic tool designed for the qualitative detection of Dengue Virus NS1 antigen in human serum, plasma, or whole blood. Configured for 50 tests, this kit provides a convenient and efficient solution for the early diagnosis of Dengue virus infection.

Key Features:

  1. Early Detection of Dengue Virus: The rapid card is specifically designed for the early detection of Dengue Virus NS1 antigen, allowing for prompt identification of Dengue virus infection during the acute phase of the illness.

  2. Rapid Results On-Site: With a rapid testing procedure, the kit provides on-the-spot results within a short timeframe. This feature is crucial for quick clinical decision-making and timely patient management.

  3. Triple Specimen Compatibility: The test is compatible with human serum, plasma, and whole blood specimens, providing flexibility in sample collection and making it suitable for various healthcare settings.

  4. 50-Test Configuration: The kit includes 50 tests, offering an efficient solution for healthcare facilities with moderate to high testing volumes. This configuration supports multiple screening sessions and facilitates widespread Dengue virus testing.


  1. Timely Identification of Dengue Infection: The early detection of Dengue Virus NS1 antigen allows for the timely identification of Dengue virus infection, facilitating appropriate patient management during the acute phase of the illness.

  2. Rapid On-Site Results: The rapid card design enables quick and on-the-spot testing, providing results within a short duration. This feature is advantageous for immediate clinical decision-making and patient care.

  3. Versatile Specimen Compatibility: Compatibility with human serum, plasma, and whole blood specimens enhances flexibility in sample collection, making the test adaptable to diverse healthcare settings and conditions.

Sold by Biogenix Inc Pvt Ltd & fulfilled byMedikabazaar